Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Marnix Lameijer; Tina Binderup; Mandy M. T. van Leent; Max L. Senders; Francois Fay; Joost Malkus; Brenda L. Sanchez-Gaytan; Abraham J. P. Teunissen; Nicolas Karakatsanis; Philip Robson; Xianxiao Zhou; Yuxiang Ye; Gregory Wojtkiewicz; Jun Tang; Tom T. P. Seijkens; Jeffrey Kroon; Erik S. G. Stroes; Andreas Kjaer; Jordi Ochando; Thomas Reiner; Carlos Pérez-Medina; Claudia Calcagno; Edward A. Fisher; Bin Zhang; Ryan E. Temel; Filip K. Swirski; Matthias Nahrendorf; Zahi A. Fayad; Esther Lutgens; Willem J. M. Mulder; Raphaël Duivenvoorden

doi:https://doi.org/10.1038/s41551-018-0281-3

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Marnix Lameijer, Tina Binderup, Mandy M. T. van Leent, Max L. Senders, Francois Fay, Joost Malkus, Brenda L. Sanchez-Gaytan, Abraham J. P. Teunissen, Nicolas Karakatsanis, Philip Robson, Xianxiao Zhou, Yuxiang Ye, Gregory Wojtkiewicz, Jun Tang, Tom T. P. Seijkens, Jeffrey Kroon, Erik S. G. Stroes, Andreas Kjaer, Jordi Ochando, Thomas ReinerCarlos Pérez-Medina, Claudia Calcagno, Edward A. Fisher, Bin Zhang, Ryan E. Temel, Filip K. Swirski, Matthias Nahrendorf, Zahi A. Fayad, Esther Lutgens, Willem J. M. Mulder, Raphaël Duivenvoorden

Research output: Contribution to journal › Erratum/Corrigendum › Academic

2 Citations (Scopus)

Abstract

In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.

Original language	English
Pages (from-to)	623
Journal	Nature Biomedical Engineering
Volume	2
Issue number	8
DOIs	https://doi.org/10.1038/s41551-018-0281-3
Publication status	Published - 2018

Access to Document

https://doi.org/10.1038/s41551-018-0281-3

Cite this

Lameijer, M., Binderup, T., van Leent, M. M. T., Senders, M. L., Fay, F., Malkus, J., Sanchez-Gaytan, B. L., Teunissen, A. J. P., Karakatsanis, N., Robson, P., Zhou, X., Ye, Y., Wojtkiewicz, G., Tang, J., Seijkens, T. T. P., Kroon, J., Stroes, E. S. G., Kjaer, A., Ochando, J., ... Duivenvoorden, R. (2018). Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2). Nature Biomedical Engineering, 2(8), 623. https://doi.org/10.1038/s41551-018-0281-3

@article{452acd6c74a9420da557a3442eeeb4f4,

title = "Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)",

abstract = "In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as {\textquoteleft}Fischer{\textquoteright}. This has now been corrected.",

author = "Marnix Lameijer and Tina Binderup and {van Leent}, {Mandy M. T.} and Senders, {Max L.} and Francois Fay and Joost Malkus and Sanchez-Gaytan, {Brenda L.} and Teunissen, {Abraham J. P.} and Nicolas Karakatsanis and Philip Robson and Xianxiao Zhou and Yuxiang Ye and Gregory Wojtkiewicz and Jun Tang and Seijkens, {Tom T. P.} and Jeffrey Kroon and Stroes, {Erik S. G.} and Andreas Kjaer and Jordi Ochando and Thomas Reiner and Carlos P{\'e}rez-Medina and Claudia Calcagno and Fisher, {Edward A.} and Bin Zhang and Temel, {Ryan E.} and Swirski, {Filip K.} and Matthias Nahrendorf and Fayad, {Zahi A.} and Esther Lutgens and Mulder, {Willem J. M.} and Rapha{\"e}l Duivenvoorden",

year = "2018",

doi = "https://doi.org/10.1038/s41551-018-0281-3",

language = "English",

volume = "2",

pages = "623",

journal = "Nature Biomedical Engineering",

issn = "2157-846X",

publisher = "Nature Publishing Group",

number = "8",

}

Lameijer, M, Binderup, T, van Leent, MMT, Senders, ML, Fay, F, Malkus, J, Sanchez-Gaytan, BL, Teunissen, AJP, Karakatsanis, N, Robson, P, Zhou, X, Ye, Y, Wojtkiewicz, G, Tang, J, Seijkens, TTP , Kroon, J , Stroes, ESG, Kjaer, A, Ochando, J, Reiner, T, Pérez-Medina, C, Calcagno, C, Fisher, EA, Zhang, B, Temel, RE, Swirski, FK, Nahrendorf, M, Fayad, ZA, Lutgens, E, Mulder, WJM & Duivenvoorden, R 2018, 'Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)', Nature Biomedical Engineering, vol. 2, no. 8, pp. 623. https://doi.org/10.1038/s41551-018-0281-3

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2). / Lameijer, Marnix; Binderup, Tina; van Leent, Mandy M. T. et al.
In: Nature Biomedical Engineering, Vol. 2, No. 8, 2018, p. 623.

Research output: Contribution to journal › Erratum/Corrigendum › Academic

TY - JOUR

T1 - Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

AU - Lameijer, Marnix

AU - Binderup, Tina

AU - van Leent, Mandy M. T.

AU - Senders, Max L.

AU - Fay, Francois

AU - Malkus, Joost

AU - Sanchez-Gaytan, Brenda L.

AU - Teunissen, Abraham J. P.

AU - Karakatsanis, Nicolas

AU - Robson, Philip

AU - Zhou, Xianxiao

AU - Ye, Yuxiang

AU - Wojtkiewicz, Gregory

AU - Tang, Jun

AU - Seijkens, Tom T. P.

AU - Kroon, Jeffrey

AU - Stroes, Erik S. G.

AU - Kjaer, Andreas

AU - Ochando, Jordi

AU - Reiner, Thomas

AU - Pérez-Medina, Carlos

AU - Calcagno, Claudia

AU - Fisher, Edward A.

AU - Zhang, Bin

AU - Temel, Ryan E.

AU - Swirski, Filip K.

AU - Nahrendorf, Matthias

AU - Fayad, Zahi A.

AU - Lutgens, Esther

AU - Mulder, Willem J. M.

AU - Duivenvoorden, Raphaël

PY - 2018

Y1 - 2018

N2 - In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.

AB - In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85050955422&origin=inward

U2 - https://doi.org/10.1038/s41551-018-0281-3

DO - https://doi.org/10.1038/s41551-018-0281-3

M3 - Erratum/Corrigendum

C2 - 31015637

SN - 2157-846X

VL - 2

SP - 623

JO - Nature Biomedical Engineering

JF - Nature Biomedical Engineering

IS - 8

ER -

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J et al. Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2). Nature Biomedical Engineering. 2018;2(8):623. doi: https://doi.org/10.1038/s41551-018-0281-3

Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Abstract

Access to Document

Other files and links

Cite this